


Another NameLuciLenacap,来那帕韦纳
IndicationsIn combination with other antiretroviral drugs, it is indicated for the treatment of heavily treated adult HIV-1-infected patients with multidrug resistance whose current antiretroviral treatment regi
Reg No.03 L 1316/25
Inspection No.647-25
WhatsApp: